These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Antiplatelet therapy (first of two parts). Weiss HJ N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993 [No Abstract] [Full Text] [Related]
24. Deposition of human labeled platelets to damaged rabbit aorta before and after use of sulfinpyrazone in patients with acute myocardial infarction. Jaeger S; Berntsen H Haemostasis; 1980; 9(5):257-62. PubMed ID: 7409611 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results. Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375 [TBL] [Abstract][Full Text] [Related]
26. Effects of copper-aspirin complex on platelet-neutrophil interactions. Shen ZQ; Chen P; Li L; Chen P; Liu WP Acta Pharmacol Sin; 2004 May; 25(5):576-80. PubMed ID: 15132821 [TBL] [Abstract][Full Text] [Related]
27. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition. Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274 [TBL] [Abstract][Full Text] [Related]
28. Effects of 0-/-B-hydroxyethyl/rutoside on platelet function and thrombus formation in rat mesenteric vessels. Krupiński K; Breddin HK; Giedrojć J; Bodzenta-Lukaszyk A; Bielawiec M Mater Med Pol; 1995; 27(2):39-42. PubMed ID: 8935187 [TBL] [Abstract][Full Text] [Related]
29. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis. Weiss HJ Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989 [No Abstract] [Full Text] [Related]
31. Inhibitory effects of nimodipine on platelet aggregation and thrombosis. Ren YJ; Lü AG; Zhang GQ; Jia DH Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):158-60. PubMed ID: 10374642 [TBL] [Abstract][Full Text] [Related]
32. Sulfinpyrazone: a review of its pharmacological properties and therapeutic use. Margulies EH; White AM; Sherry S Drugs; 1980 Sep; 20(3):179-97. PubMed ID: 7000488 [TBL] [Abstract][Full Text] [Related]
33. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets. Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274 [TBL] [Abstract][Full Text] [Related]
34. [Antithrombotic effect of daphnetin in the rat]. Qu SY; Jiang XL; Zhao XH; Pan DB; Wang XR; Chen YL; Pan G; Wu YJ Yao Xue Xue Bao; 1986 Jul; 21(7):498-501. PubMed ID: 3811938 [No Abstract] [Full Text] [Related]
35. Platelet reactivity ex vivo and in vivo after acute and chronic treatment with sodium caprylate. Tangen O; Wallenbeck IA; Bergqvist D Scand J Clin Lab Invest; 1975 Jan; 35(1):19-23. PubMed ID: 1129590 [TBL] [Abstract][Full Text] [Related]
39. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs. Buchanan M; Hirsh J Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423 [No Abstract] [Full Text] [Related]
40. [Morphofunctional characteristics of the bipolar forms of thrombocytes]. Buriachkovskaia LI; Markosian RA Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):66-72. PubMed ID: 3606835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]